Computational Health

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

Scientists at Helmholtz Munich, together with Harvard Medical School and international collaborators, have developed TITAN, an artificial intelligence (AI) model capable of analyzing and describing digital pathology slides. By combining information…

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics. Trained on more than 110 million cells,…

Helmholtz Munich had the pleasure to welcome Prof. Eric Topol, internationally recognized cardiologist, geneticist, and digital medicine expert, for a roundtable on the future of AI in healthcare. The event, serving as a prologue to the Bavarian…

A recent study led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, provides new insights into how genetic risk for type 2 diabetes (T2D) can influence a wide range of health conditions beyond…

When immune system killer cells detect signs of infection, some of them rapidly multiply, forming a large defensive force to fight the pathogen. However, this response does not occur in every killer cell. What determines whether a cell will…

Computational Health

News

Helmholtz Munich to Advance AI Benchmarking With Three Newly Funded Projects

TITAN: A Multimodal AI Model for Digital Pathology Slides

New Foundation Model Reveals How Cells Are Organized in Tissues

Prof. Eric Topol Visits Helmholtz Munich for Roundtable on “Virtual Human”

Genetic Links Between Type 2 Diabetes and Multiple Health Conditions

Investigating a Fundamental Biological Process in Vaccinated Individuals